ArticlePloS one2022

Performance characteristics of the first Food and Drug Administration (FDA)-cleared digital droplet PCR (ddPCR) assay for BCR::ABL1 monitoring in chronic myelogenous leukemia.

Dawne N Shelton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.